Joint Filing AgreementJoint Filing Agreement • May 18th, 2015 • Shapiro Gary L • Services-prepackaged software
Contract Type FiledMay 18th, 2015 Company IndustryThe undersigned hereby agree that the statements on Schedule 13D with respect to the Common Stock of Bulova Technologies Group, Inc. dated as of February 25, 2013 is, and any amendments thereto (including amendments on Schedule 13G), signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Joint Filing AgreementJoint Filing Agreement • January 2nd, 2015 • Shapiro Gary L • Services-prepackaged software
Contract Type FiledJanuary 2nd, 2015 Company IndustryThe undersigned hereby agree that the statements on Schedule 13D with respect to the Common Stock of Bulova Technologies Group, Inc. dated as of February 25, 2013 is, and any amendments thereto (including amendments on Schedule 13G), signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
JOINT FILING AGREEMENTJoint Filing Agreement • January 7th, 2008 • HSBC International Trustee • Services-business services, nec
Contract Type FiledJanuary 7th, 2008 Company IndustryThe undersigned hereby agree that the Statement on Schedule 13G, dated January 7, 2008 (the “Schedule 13G”), with respect to the ordinary shares, par value $0.01 per share, of Shanda Interactive Entertainment Limited is, and any amendments executed by us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an exhibit to the Schedule 13G and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • October 22nd, 2007 • Neurochem Inc • Pharmaceutical preparations
Contract Type FiledOctober 22nd, 2007 Company IndustryWe, the undersigned, agree that the attached Amendment to the Schedule 13D relating to the common stock of Neurochem Inc., is filed on behalf of each of us.
JOINT FILING AGREEMENTJoint Filing Agreement • August 21st, 2007 • Arco Capital Corp LTD • Real estate investment trusts
Contract Type FiledAugust 21st, 2007 Company IndustryIn accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and any amendments to it with respect to the shares of common stock, par value $0.001 per share, of Luminent Mortgage Capital, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to those joint filings.
Joint Filing AgreementJoint Filing Agreement • April 25th, 2006 • Albert & Margaret Alkek Foundation • Pharmaceutical preparations
Contract Type FiledApril 25th, 2006 Company IndustryIn accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and all amendments thereto with respect to the Common Stock, par value $0.05 per share, of PharmaFrontiers Corp. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.
Joint Filing AgreementJoint Filing Agreement • April 24th, 2006 • Albert & Margaret Alkek Foundation • Pharmaceutical preparations
Contract Type FiledApril 24th, 2006 Company IndustryIn accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a Statement on Schedule 13D and all amendments thereto with respect to the Common Stock, par value $0.05 per share, of PharmaFrontiers Corp. beneficially owned by each of them, and to the inclusion of this Joint Filing Agreement as an exhibit thereto.